Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | $539.5M | $559.6M | $563.9M | $612.1M | $555.2M | $578.3M | $588.1M | $485.7M | — | — | — | — | — | — | — |
| EBITDAderived | — | — | — | $783.1M | $779.2M | $766.9M | $830.8M | $754.9M | $762.1M | $760.7M | $625.4M | — | — | — | — | — | — | — |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M | $284.2M | $358.7M | $292.3M | $271.1M | $247.6M | $183.1M | $222.0M | $323.6M | $185.0M | $208.7M | $899.0M | $94.8M | $252.4M |
| Basic EPSper diluted share | $5.62 | $4.53 | $3.51 | $2.72 | $4.15 | $2.87 | $3.65 | $2.98 | $2.88 | $2.77 | $2.02 | $2.46 | $2.58 | $1.67 | $1.91 | $9.41 | $0.77 | $2.73 |
| Diluted EPSper diluted share | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 | $1.91 | $2.29 | $2.58 | $1.67 | $1.96 | $8.28 | $0.77 | $2.62 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026Form 4 | COLTHARP DOUGLAS EEVP & Chief Financial Officer | SellEncompass Health Common Stock | 1 | $107.28 | $107.28 | 69.4K |
| May 15, 2026Form 4 | COLTHARP DOUGLAS EEVP & Chief Financial Officer | SellEncompass Health Common Stock | 27.7K | $106.83 | $2.96M | 69.4K |
| May 11, 2026Form 4 | Tuer Patrick WilliamEVP, Chief Operating Officer | SellEncompass Health Common Stock | 682 | $104.56 | $71.3K | 24.8K |
| Mar 9, 2026Form 4 | Fay EdmundSr. Vice Pres. and Treasurer | SellEncompass Health Common Stock | 11.9K | $107.00 | $1.28M | 89.3K |
| Feb 11, 2026Form 4 | Tarr Mark JPresident & CEO | SellEncompass Health Common Stock | 213 | $113.58 | $24.2K | 377.1K |